Who are Lupron (leuprolide acetate)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Leuprolide acetate in depot suspension, Lupron Trigger, Leuprolide (GnRH agonists), Half-Dose Depot Triptorelin, Leuprolide Depot, Ultra-Long GnRH Agonists + Letrozole.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/lupron-leuprolide-acetate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Lupron (leuprolide acetate) — Competitive Intelligence Brief

Lupron (leuprolide acetate) (Lupron (leuprolide acetate)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: GnRH agonist. Area: Oncology.

phase 3 GnRH agonist GnRH receptor (GNRHR) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Lupron (leuprolide acetate) (Lupron (leuprolide acetate)) — Abbott. Leuprolide is a GnRH agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to decreased testosterone and estrogen production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Lupron (leuprolide acetate) TARGET	Lupron (leuprolide acetate)	Abbott	phase 3	GnRH agonist	GnRH receptor (GNRHR)
Leuprolide acetate in depot suspension	Leuprolide acetate in depot suspension	Colorado Center for Reproductive Medicine	marketed	GnRH agonist	GnRH receptor
Lupron Trigger	Lupron Trigger	Weill Medical College of Cornell University	marketed	GnRH agonist	GnRH receptor
Leuprolide (GnRH agonists)	Leuprolide (GnRH agonists)	University of Pisa	marketed	GnRH agonist	GnRH receptor (GNRHR)
Half-Dose Depot Triptorelin	Half-Dose Depot Triptorelin	Tehran University of Medical Sciences	marketed	GnRH agonist	GnRH receptor
Leuprolide Depot	Leuprolide Depot	Enteris BioPharma Inc.	marketed	GnRH agonist	GnRH receptor
Ultra-Long GnRH Agonists + Letrozole	Ultra-Long GnRH Agonists + Letrozole	University of Palermo	marketed	GnRH agonist + aromatase inhibitor combination	GnRH receptor; aromatase (CYP19A1)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (GnRH agonist class)

Takeda · 4 drugs in this class
Abbott · 3 drugs in this class
Ipsen · 3 drugs in this class
Changchun GeneScience Pharmaceutical Co., Ltd. · 3 drugs in this class
University of Pisa · 2 drugs in this class
Chong Qing Reproducive and Genetic Institute · 1 drug in this class
Chesapeake Urology Research Associates · 1 drug in this class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 drug in this class
Enteris BioPharma Inc. · 1 drug in this class
Colorado Center for Reproductive Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Lupron (leuprolide acetate) — Competitive Intelligence Brief. https://druglandscape.com/ci/lupron-leuprolide-acetate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab